Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $44.7B |
| FY2017, ended Dec 31, 2017 | $58.0B |
| FY2018, ended Dec 31, 2018 | $58.4B |
| FY2019, ended Dec 31, 2019 | $78.6B |
| FY2020, ended Dec 31, 2020 | $92.2B |
| FY2021, ended Dec 31, 2021 | $101B |
| FY2022, ended Dec 31, 2022 | $92.6B |
| FY2023, ended Dec 31, 2023 | $114B |
| FY2024, ended Dec 31, 2024 | $137B |
| FY2025, ended Dec 31, 2025 | $135B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $121B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $11.3B |
| FY2017, ended Dec 31, 2017 | $12.4B |
| FY2018, ended Dec 31, 2018 | $13.6B |
| FY2019, ended Dec 31, 2019 | $14.9B |
| FY2020, ended Dec 31, 2020 | $14.4B |
| FY2021, ended Dec 31, 2021 | $17.1B |
| FY2022, ended Dec 31, 2022 | $18.4B |
| FY2023, ended Dec 31, 2023 | $20.5B |
| FY2024, ended Dec 31, 2024 | $22.6B |
| FY2025, ended Dec 31, 2025 | $25.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $25.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.65B | $1.43B |
| FY2017, ended Dec 31, 2017 | $1.02B | $961M |
| FY2018, ended Dec 31, 2018 | $3.55B | $2.04B |
| FY2019, ended Dec 31, 2019 | $2.08B | $1.54B |
| FY2020, ended Dec 31, 2020 | $1.60B | $2.79B |
| FY2021, ended Dec 31, 2021 | $1.99B | $2.74B |
| FY2022, ended Dec 31, 2022 | $2.36B | $2.04B |
| FY2023, ended Dec 31, 2023 | $3.17B | $3.14B |
| FY2024, ended Dec 31, 2024 | $2.99B | $3.49B |
| FY2025, ended Dec 31, 2025 | $3.25B | $4.28B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.73B | $4.70B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.32B |
| FY2017, ended Dec 31, 2017 | $2.54B |
| FY2018, ended Dec 31, 2018 | $3.62B |
| FY2019, ended Dec 31, 2019 | $4.34B |
| FY2020, ended Dec 31, 2020 | $2.94B |
| FY2021, ended Dec 31, 2021 | $2.94B |
| FY2022, ended Dec 31, 2022 | $1.84B |
| FY2023, ended Dec 31, 2023 | $2.97B |
| FY2024, ended Dec 31, 2024 | $3.65B |
| FY2025, ended Dec 31, 2025 | $4.01B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.39B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.91B |
| FY2017, ended Dec 31, 2017 | $7.22B |
| FY2018, ended Dec 31, 2018 | $9.86B |
| FY2019, ended Dec 31, 2019 | $11.1B |
| FY2020, ended Dec 31, 2020 | $14.0B |
| FY2021, ended Dec 31, 2021 | $12.5B |
| FY2022, ended Dec 31, 2022 | $13.0B |
| FY2023, ended Dec 31, 2023 | $13.0B |
| FY2024, ended Dec 31, 2024 | $13.6B |
| FY2025, ended Dec 31, 2025 | $15.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 2.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 373M |
| FY2017, ended Dec 31, 2017 | 375M |
| FY2018, ended Dec 31, 2018 | 373M |
| FY2019, ended Dec 31, 2019 | 375M |
| FY2020, ended Dec 31, 2020 | 376M |
| FY2021, ended Dec 31, 2021 | 378M |
| FY2022, ended Dec 31, 2022 | 379M |
| FY2023, ended Dec 31, 2023 | 380M |
| FY2024, ended Dec 31, 2024 | 382M |
| FY2025, ended Dec 31, 2025 | 383M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 384M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $13.0M | $97.0M |
| FY2017, ended Dec 31, 2017 | $230M | $113M |
| FY2018, ended Dec 31, 2018 | $300M | $119M |
| FY2019, ended Dec 31, 2019 | $307M | $127M |
| FY2020, ended Dec 31, 2020 | $0 | $142M |
| FY2021, ended Dec 31, 2021 | $0 | $171M |
| FY2022, ended Dec 31, 2022 | — | $168M |
| FY2023, ended Dec 31, 2023 | — | $205M |
| FY2024, ended Dec 31, 2024 | — | $229M |
| FY2025, ended Dec 31, 2025 | — | $243M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $251M |
Valuation
At current price- Market Cap
- $116B
- P/E
- 31.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.5×
- Price / Book
- 4.8×
- EV / EBITDA
- 17.8×
Growth
Trailing 12 months- Revenue (TTM)
- $25.8B
- Revenue Growth YoY
- 8.5%
- Revenue CAGR 3Y
- 10.8%
- Revenue CAGR 5Y
- 11.8%
- EPS Growth YoY
- 27.8%
- Net Income Growth YoY
- 27.8%
Profitability
Trailing 12 months- Gross Margin
- 65.0%
- Operating Margin
- 21.4%
- Net Margin
- 14.4%
- FCF Margin
- 18.2%
- Return on Equity
- 16.5%
Earnings
Trailing 12 months- Net Income
- $3.73B
- EPS (diluted)
- $9.65
- EBITDA
- $7.15B
- Operating Income
- $5.53B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $3.39B
- Total Debt
- $14.9B
- Net Debt
- $11.6B
- Total Assets
- $47.9B
- Total Liabilities
- $23.9B
- Shareholders' Equity
- $24.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.53B
- Capital Expenditure
- $823M
- Free Cash Flow
- $4.70B
Dividends and risk
Last 12 months- Dividend Yield
- 1.2%
- Dividend / Share
- $3.52
- Beta (5Y)
- 0.77
Every ratio is calculated from the company’s reported figures.